Unprecedented benefit seen in worldwide test of a three-drug treatment for multiple myeloma

7 diciembre 2014

In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team.